New drug trial offers hope for Tough-to-Treat head and neck cancer

NCT ID NCT05126719

Summary

This study is testing an experimental drug called MRG003 for people with advanced nasopharyngeal cancer that has returned or spread after previous treatments. It aims to see if MRG003 can shrink tumors and control the disease better than current standard chemotherapy options. The trial is for adults whose cancer has continued to grow despite trying at least one or two prior lines of therapy.

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for RECURRENT OR METASTATIC NASOPHARYNGEAL CARCINOMA are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Contacts and locations

Locations

  • Cancer Hospital of Shantou University Medical College

    Shantou, Guangdong, 515041, China

  • Chongqing University Cancer Hospital

    Chongqing, Chongqing Municipality, 400030, China

  • First Affiliated Hospital of Gannan Medical University

    Ganzhou, Jiangxi, 341001, China

  • Fujian Cancer Hospital

    Fuzhou, Fujian, 350014, China

  • Ganzhou Cancer Hospital

    Ganzhou, Jiangxi, 341005, China

  • Guangxi Medical University Affiliated Tumor Hospital

    Nanning, Guangxi, 530021, China

  • Guigang City People's Hospital

    Guigang, Guangxi, 537199, China

  • Hainan General Hospital

    Haikou, Hainan, 570311, China

  • Henan Cancer Hospital

    Zhengzhou, Henan, 450003, China

  • Hunan Cancer Hospital

    Changsha, Hunan, 410031, China

  • Jiangxi Cancer Hospital

    Nanchang, Jiangxi, 330029, China

  • Maoming People's Hospital

    Maoming, Guangdong, 525000, China

  • Peking University Cancer Hospital

    Beijing, Beijing Municipality, 100142, China

  • People's Hospital of Guangxi Zhuang Autonomous Region

    Nanning, Guangxi, 530021, China

  • Shanghai East Hospital

    Shanghai, Shanghai Municipality, 200123, China

  • Sichuan Cancer Hospital

    Chengdu, Sichuan, 610041, China

  • Sun Yat-sen University Cancer Center

    Guangzhou, Guangdong, 510000, China

  • The Affiliated Cancer Hospital of Guizhou Medical University

    Guiyang, Guizhou, 550000, China

  • Union Hospital, Tongji Medical College, Huazhong University of Science and Technology

    Wuhan, Hubei, 430022, China

  • Yibin Second People's Hospital

    Yibin, Sichuan, 644000, China

  • Yue Bei People's Hospital

    Shaoguan, Guangdong, 512026, China

  • Zhejiang Cancer Hospital

    Hangzhou, Zhejiang, 310022, China

  • Zhongshan City People's Hospital

    Zhongshan, Guangdong, 528403, China

Conditions

Explore the condition pages connected to this study.